Get to know Eric Lefkofsky

There is a cure for cancer, it is just taking a much longer process to find. Many people out there continue to search for the cure, in hopes for a better tomorrow.Eric Lefkofsky, the founder of Groupon, is now part of Tempus, “a health tech start-up” that can modernize cancer treatments for patients. Tempus is helping doctors with their research to find the exact formulation for a patient’s condition. For this research practice, Lefkofsky has created a charity fund called Lefkofsky’s Family Foundation. He has donated over billions of dollars to this cause so that universities and researchers are able to find the solution. Overall, with continuous research, doctors will be able to prescribe the most accurate medicine for their patient’s condition.

His education has exceeded expectations for his credibility. He has acquired degrees and references from the University of Michigan and Doctor of Jurisprudence. The University of Michigan is a 200-year-old traditional college which excels their students in medicine, research, and even sports. There are so many historical moments that have happened at the University of Michigan. For example, Thomas Francis Jr. had founded a “safe, effective, and potent” polio vaccine for those suffering from the disease. In addition, it was one of the most peaceful acts of helping patients of more than 325,000 doctors volunteering. It was a successful outcome which had the country celebrating the great news. With that said, Eric Lefkofsky is coming from a credible school of over 200 years of excellence with history records to prove it. You can also follow him on twitter : https://twitter.com/lefkofsky

With Lefkofsky’s dedicated staff and recent billionaire investors, he is helping trillions of people around the world with Tempus. He is making a better tomorrow for the sick people who need all the help they can get. His education and business background show his worth but his generosity proves that he is here to help people. His foundation is located in Chicago and it is definitely possible to call and learn more.If we as people keep holding onto hope that we can have a better tomorrow, then we can make curing cancer possible.

Seattle Genetics leader Clay Siegall Leads steps into finding the Cure for Cancer

Just like Silicon Valley is reputable for its cell phone, electronic and computer research, Seattle is the present cancer research center. Seattle has lately become a medical drug research hub where scientists are uniting to create the friendliest working environment. Good climate and plenty of nearby natural resources favor scientific research.

Clay Siegall’s contributions towards cancer treatment

Clay Siegall is one of the most experienced Seattle therapeutic drug and cancer research developers. He is driven by the motivation to discover cures for the many diseases that are destroying savings accounts and depleting family and company insurance funds. At the peak of his efforts to find corrective measures for cancer, Dr. Clay has shown commitment to helping all medical development aspects.

Beginning his education at the Maryland Zoology University, Dr. Clay later attained his Ph.D. from the University of George Washington. He went on to serve at the National Cancer Institute as well as the Bristol Meyers Squibb Pharmaceutical Research Institute.

He later founded his company, the Seattle Genetics where he serves as the enterprise research board director. Besides, Seattle Genetics, Dr. Clay also serves as the board director of Alder Biopharmaceuticals, Fred Hutchinson Cancer Research Business Alliance, and the American Biomedical Association.

Dr. Clay established Seattle Genetics on scientific innovation foundation, passion for helping patients as well as drug development practices. At Seattle Genetics, Dr. Clay has continuously been developing the range of products to cure cancer and other autoimmune diseases.

He has advanced antibody technology to create a unique type of antibody drugs that selectively destroys cancerous body cells. He has overseen his company’s leadership, a position that has enabled him to develop ADCs (antibody-drug conjugates) as well as the first ever brentuximab vedotin product. In partnership with the Takeda Pharmaceutical Company, Seattle Genetics has diversified into ADCs pipeline proprietary for cancer treatment.

Very often, the current cancer treatments have been too destructive and invasive. Most cancer treatments have often reduced the level of cancer cells in the body but left the human body too weak. Cancer continues to plague the society, leaving the kinds of Clay Siegall and Seattle Generics in desperate need to find cures.